Fluor Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting third-quarter revenue of $3.72 billion and a return to operating profit after a substantial loss in the year-earlier quarter.
Key Highlights
- Revenue rose to $3,720 million for the three months ended September 30, 2026, up from $3,368 million in the same quarter of 2025, according to the filing.
- Gross profit of $203 million was reported for the 2026 quarter, compared with a gross loss of $449 million in the 2025 quarter.
- Operating profit of $225 million for Q3 2026 reversed an operating loss of $496 million in Q3 2025; the 2026 quarter included a $73 million gain on the sale of Fluor's interest in ICA-Fluor and CFHI.
- Net earnings attributable to Fluor were $158 million, or $1.16 per diluted share, for the 2026 quarter, versus a net loss of $697 million, or $4.30 per diluted share, in the year-ago quarter.
- Nine-month revenue reached $11,711 million, compared with $11,327 million for the nine months ended September 30, 2025.
- Shares outstanding were 128,184,260 as of October 30, 2026, down from 152,047,739 shares issued and outstanding at December 31, 2025.
- Total assets stood at $7,253 million at September 30, 2026, versus $8,236 million at December 31, 2025; the balance sheet reflects the absence of the NuScale investment, which was $1,579 million at year-end 2025 and $0 at September 30, 2026.
Fluor's Third-Quarter 2026 Financial Results: Key Figures and Year-Over-Year Changes
According to the filing, Fluor Corporation (NYSE:FLR) reported revenue of $3,720 million for the three months ended September 30, 2026, an increase from $3,368 million in the comparable 2025 quarter. Cost of revenue for the 2026 quarter was $3,517 million, compared with $3,817 million a year earlier, producing a gross profit of $203 million versus a gross loss of $449 million. The company also reported a $73 million gain on the sale of its interest in ICA-Fluor and CFHI during the quarter, contributing to operating profit of $225 million, which reversed the prior-year quarter's operating loss of $496 million.
For the nine months ended September 30, 2026, the filing disclosed revenue of $11,711 million and operating profit of $450 million. The nine-month period also included a cumulative $197 million gain on the sale of interests in ICA-Fluor and CFHI. Net earnings attributable to Fluor for the nine-month period were $432 million, or $3.04 per diluted share, compared with $1,522 million, or $9.13 per diluted share, in the nine months ended September 30, 2025 - the prior-year figure was significantly influenced by equity method earnings of $2,418 million, primarily related to NuScale.
The condensed consolidated balance sheet as of September 30, 2026, shows total assets of $7,253 million and total equity of $2,699 million. Cash and cash equivalents were $2,678 million, up from $2,135 million at December 31, 2025. The filing notes proceeds from the sale of NuScale shares of $1,831 million in the nine-month investing cash flow period. Operating cash flow for the nine months ended September 30, 2026, was negative $21 million, the same as in the comparable 2025 period. General and administrative expense was $52 million for the 2026 quarter, compared with $43 million for the 2025 quarter.
What Was Disclosed
Fluor's 10-Q for the quarter ended September 30, 2026, disclosed quarterly and nine-month income statement results, a condensed balance sheet reflecting the disposition of the NuScale investment, cash flow data, and share count information as of October 30, 2026.



Please wait processing your request...